Mucosal and systemic immunization against tuberculosis by ISCOMATRIX nano adjuvant co-administered with alginate coated chitosan nanoparticles
Objective(s): BCG vaccine has no longer been appreciated to immunize against tuberculosis, worldwide, so novel appropriate adjuvants have been dedicated to improve immune responses. This study aimed to evaluate the immunomodulatory effects of ISCOMATRIX as an adjuvant to stimulate potent humoral and...
Main Authors: | Adel Najafi, Kiarash Ghazvini, Mojtaba Sankian, Leila Gholami, Sirvan Zare, Arshid Youdefi-Avarvand, Mohsen Tafaghodi |
---|---|
Format: | Article |
Language: | English |
Published: |
Mashhad University of Medical Sciences
2023-10-01
|
Series: | Iranian Journal of Basic Medical Sciences |
Subjects: | |
Online Access: | https://ijbms.mums.ac.ir/article_22667_5e9cbf45793c425696386ac81eddba20.pdf |
Similar Items
-
Enhancement of the immunogenicity of a Mycobacterium tuberculosis fusion protein using ISCOMATRIX and PLUSCOM nano-adjuvants as prophylactic vaccine after nasal administration in mice
by: Arshid Yousefi Avarvand, et al.
Published: (2024-01-01) -
The role of surface charge of ISCOMATRIX nanoparticles on the type of immune response generated against Leishmaniasis in BALB/c mice
by: Ahmad Mehravaran, et al.
Published: (2015-10-01) -
Preliminary studies on the formulation of immune stimulating complexes using saponin from Carica papaya leaves
by: Chioma Miracle Ojiako, et al.
Published: (2019-06-01) -
Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?
by: Farzad Khademi, et al.
Published: (2018-01-01) -
Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines
by: Huub F. J. Savelkoul, et al.
Published: (2015-03-01)